[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Conditions](https://durgical.com/en/conditions/) › HIV pre-exposure and post-exposure prophylaxis (PrEP and PEP)

# HIV pre-exposure and post-exposure prophylaxis (PrEP and PEP)

Antiretroviral drugs can stop HIV from taking hold: taken before exposure (PrEP) by people at ongoing risk, or started within 72 hours after one (PEP).

Updated Nov 19, 2026

On this page

- The basics What it is
- How to think about it
- Who gets it
- Causes
- Risk factors
- Pathophysiology
- Classification
- PrEP or PEP?
- Common traps

- Clinical Symptoms and signs
- Diagnosis
- Differential diagnosis
- Complications
- Prognosis

- Treatment Goal of treatment
- Treatment
- Prevention

- Study Test yourself

- Connections Connections

## What it is

Use of antiretroviral drugs by a person without HIV to prevent infection. PrEP is taken before and during periods of risk; PEP is a short course started as soon as possible, and within 72 hours, after a sexual, injection or occupational exposure. Both require a negative HIV test and follow-up testing.

## How to think about it

PrEP is a seatbelt, PEP is an airbag that only works if it fires in time. After exposure the virus first replicates in local tissue and draining lymph nodes for about three days before it seeds the body; drugs given in that window can still stop it, after it they cannot. Either way, test before you buckle up: giving prevention-level drugs to someone who already has HIV breeds resistance.

See it in 3D

- [Vagina](https://durgical.com/en/anatomy/vagina/)
- [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/)
- [Glans penis](https://durgical.com/en/anatomy/glans-of-penis/)
- [Rectum](https://durgical.com/en/anatomy/rectum/)

## +3

- [Anal canal](https://durgical.com/en/anatomy/anal-canal/)
- [Spongy urethra](https://durgical.com/en/anatomy/spongy-urethra/)
- [Superficial inguinal nodes](https://durgical.com/en/anatomy/superficial-inguinal-nodes/)

## Who gets it

Colombia's national response places PrEP inside combination prevention, prioritising men who have sex with men, transgender women, sex workers, people who inject drugs and partners of people with HIV who are not virally suppressed; the Ministry's 2023 guideline sets out how it is offered. Occupational PEP follows needlestick injuries in health workers; non-occupational PEP is part of the care of survivors of [sexual violence](https://durgical.com/en/conditions/sexual-violence/).

## Causes

- Estimated risk per exposure to a source with untreated HIV: receptive anal sex is the highest (about 1 in 70), then percutaneous needlestick (about 1 in 300), insertive anal or vaginal sex, and mucous-membrane splashes (about 1 in 1000)
- Shared injecting equipment carries a high per-act risk
- Risk rises with a high source viral load, deep injury, a hollow needle with visible blood, genital ulcers or another STI
- A source on ART with a sustained undetectable viral load does not transmit HIV sexually (undetectable = untransmittable)

## Risk factors

- PrEP indications: men who have sex with men and transgender women with condomless sex, sex workers, people who inject drugs
- A partner living with HIV who is not on ART or not yet suppressed
- A bacterial STI ([syphilis](https://durgical.com/en/conditions/syphilis/), [gonorrhoea](https://durgical.com/en/conditions/gonorrhoea/), chlamydia) in the last six months
- Repeated use of PEP
- Anyone who asks for PrEP after counselling

## Pathophysiology

Virus crosses a mucosa or enters the blood → it infects local dendritic cells and CD4 T cells → over about 24 to 72 hours it amplifies and travels to regional lymph nodes → then it disseminates and the latent reservoir is established, after which infection is permanent → antiretrovirals present before exposure (PrEP) or started within the window (PEP) block reverse [transcription](https://durgical.com/en/biochemistry/topics/transcription/) or integration in the first cells, so the infection is aborted → protection depends on drug levels in the exposed tissue, which is why adherence is the main determinant of PrEP efficacy.

## Classification

- PrEP: oral daily, oral on-demand (event-driven; only for men who have sex with men) or long-acting injectable
- Occupational PEP: needlestick, cut or splash in a health worker
- Non-occupational PEP: sexual exposure (including sexual violence) or shared injecting equipment
- PEP-in-PrEP transition: a person who completes PEP and remains at risk moves straight onto PrEP

## Symptoms and signs

- Before starting either, ask about symptoms of acute HIV in the last weeks: fever, sore throat, rash, swollen glands, mouth ulcers, diarrhoea
- Such symptoms mean acute HIV until proved otherwise: an HIV RNA test is needed and prophylaxis alone is not enough
- Side effects of oral PrEP are usually mild and early: nausea, bloating, headache

## Diagnosis

**Clinical**
For PEP, assess within minutes: time since exposure (over 72 hours, PEP is not started), type of exposure, the source's HIV status and viral load if known, and whether the person is already on PrEP. For PrEP, assess ongoing risk, acute HIV symptoms and any exposure in the last 72 hours (which needs PEP first).

**Tests**
Baseline: fourth-generation HIV antigen/antibody test (plus HIV RNA if recent exposure or acute symptoms); hepatitis B surface antigen and [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/), hepatitis C; syphilis and gonorrhoea/chlamydia tests; pregnancy test; [creatinine](https://durgical.com/en/biochemistry/molecules/creatinine/) for tenofovir-based oral regimens (and [liver](https://durgical.com/en/anatomy/liver/) enzymes for PEP). Do not delay the first PEP dose waiting for results. Follow-up: after PEP, HIV testing at 4 to 6 weeks and at 12 weeks; on oral PrEP, HIV testing at least every 3 months (more often with injectables), STI tests every 3 to 6 months and creatinine periodically.

**Imaging**
Not needed.

## Differential diagnosis

- Acute HIV infection already present (needs treatment, not prophylaxis)
- Exposure with negligible risk (intact [skin](https://durgical.com/en/anatomy/skin/), saliva without blood, source with sustained undetectable viral load in sexual exposure), where PEP is not indicated
- Hepatitis B exposure, which needs vaccine with or without immune globulin, not HIV PEP alone

## PrEP or PEP?

| Feature | PrEP | PEP |
| --- | --- | --- |
| When | Before and during periods of ongoing risk | After one exposure; as soon as possible, at the latest 72 hours |
| Who | People at substantial ongoing risk, or anyone who asks | Anyone after a significant sexual, injection or occupational exposure |
| Drugs (principle) | Tenofovir-based oral pill with [emtricitabine](https://durgical.com/en/pharmacology/emtricitabine/), or long-acting injectables ([cabotegravir](https://durgical.com/en/pharmacology/cabotegravir/), [lenacapavir](https://durgical.com/en/pharmacology/lenacapavir/)) where available | Three-drug antiretroviral combination, usually integrase-inhibitor based |
| HIV test before | Must be negative; HIV RNA if acute symptoms or recent exposure | Baseline test taken, but the first dose is not delayed for the result |
| Other tests | Hepatitis B and C, STIs, creatinine, pregnancy | Hepatitis B and C, STIs, creatinine and liver enzymes, pregnancy |
| Follow-up | HIV test at least every 3 months while on PrEP | HIV test at 4 to 6 weeks and 12 weeks; offer PrEP if risk continues |

## Goal of treatment

Prevent HIV acquisition without missing an existing infection or creating drug resistance, and use every visit to prevent and treat other STIs and hepatitis.

## Treatment

**Acute**
PEP: first aid of the exposure site (wash with soap and water, irrigate mucous membranes; no squeezing or caustic agents), then start the antiretroviral combination as soon as possible and within 72 hours, completing the full course.

**Medical**
PrEP: oral tenofovir-based combination with emtricitabine taken daily (or on demand in men who have sex with men), or long-acting injectable options where approved; the choice depends on [kidney](https://durgical.com/en/anatomy/kidney/) function, hepatitis B status and preference.

**Medical**
After sexual exposure or violence: [emergency contraception](https://durgical.com/en/obstetrics-gynaecology/emergency-contraception-copper-iud-levonorgestrel-and-ulipristal/), STI prophylaxis or testing and hepatitis B vaccination (with immune globulin if the source is positive and the person not immune), alongside HIV PEP.

**Follow-up**
Follow-up HIV testing, creatinine and STI testing; with hepatitis B infection, stopping tenofovir can trigger a hepatitis flare, so this is planned with monitoring.

**Lifestyle**
Combination prevention: [condoms](https://durgical.com/en/obstetrics-gynaecology/barrier-and-fertility-awareness-methods/), adherence counselling, harm reduction for people who inject drugs, treatment of partners with HIV (undetectable = untransmittable) and [sharps safety](https://durgical.com/en/nursing/sharps-safety-and-what-to-do-after-a-needlestick/) at work.

## Complications

- HIV infection despite prophylaxis, mostly from poor adherence or late PEP
- Drug resistance when prophylaxis is given to someone with undiagnosed HIV
- Small, usually reversible fall in kidney function or bone density with [tenofovir disoproxil](https://durgical.com/en/pharmacology/tenofovir-disoproxil/)
- Hepatitis B flare after stopping tenofovir in a person with chronic hepatitis B

## Common traps

- **PEP can be started any time in the first week**: the window closes at 72 hours, and every hour counts; ideally it starts within the first day
- **PrEP can be started without an HIV test if the person looks well**: undiagnosed HIV on two-drug PrEP breeds resistance, so a negative test (and RNA if acute symptoms) comes first
- **A needlestick is riskier than receptive anal sex**: per act, receptive anal sex carries roughly four times the needlestick risk
- **PrEP protects against other STIs**: it protects only against HIV; syphilis, gonorrhoea and chlamydia need condoms, testing every 3 to 6 months and treatment
- **PEP is always needed after sex with a partner who has HIV**: a partner on ART with a sustained undetectable viral load does not transmit HIV sexually

## Prognosis

Oral PrEP taken as prescribed reduces sexual acquisition of HIV by about 99%; protection falls sharply with missed doses. PEP works best the earlier it starts; its effect beyond 72 hours is not established.

## Prevention

- Offer information about PrEP to every sexually active adult and adolescent, and PrEP to anyone at substantial risk
- Every institution offering PrEP must also recognise when PEP is needed and give it at once
- Health workers: hepatitis B vaccination, safe sharps disposal and a written route for occupational exposure
- Treatment of the partner with HIV to an undetectable viral load

## Test yourself

Think of the answer, then tap the question to see it.

## What is the latest time after exposure at which HIV PEP is started, and why?

72 hours. In that window the virus is still confined to local tissue and nodes; once it disseminates and the reservoir forms, drugs can no longer abort infection.

## Why must HIV infection be excluded before starting PrEP?

PrEP contains too few drugs to treat HIV; giving it to someone already infected selects resistant virus.

## A nurse has a hollow-needle stick from a patient of unknown status 5 hours ago. What happens first?

Wash the site, test the source if possible, take her baseline HIV, hepatitis B and C tests, and start PEP now without waiting for results; repeat HIV tests at 4 to 6 and 12 weeks.

## Which baseline result changes the choice of tenofovir-based oral PrEP and why?

Kidney function (creatinine clearance) limits tenofovir disoproxil; hepatitis B infection matters because stopping tenofovir can cause a flare.

## A man finishes PEP but will keep having condomless sex with new partners. What next?

Move directly from PEP to PrEP after a negative HIV test, without a gap.

[Add to my cards (5)](https://durgical.app/estudiar/?add=/en/conditions/hiv-pre-exposure-and-post-exposure-prophylaxis/)

## Connections

## Related conditions 8

- [HIV infection and AIDS](https://durgical.com/en/conditions/hiv-infection-and-aids/)
- [HIV-associated opportunistic infections](https://durgical.com/en/conditions/hiv-associated-opportunistic-infections/)
- [Syndromic approach to sexually transmitted infections](https://durgical.com/en/conditions/syndromic-approach-to-sexually-transmitted-infections/)
- [Syphilis](https://durgical.com/en/conditions/syphilis/)
- [Gonorrhoea](https://durgical.com/en/conditions/gonorrhoea/)
- [Chlamydia infection](https://durgical.com/en/conditions/chlamydia-infection/)
- [Viral hepatitis](https://durgical.com/en/conditions/viral-hepatitis/)
- [Sexual violence (care of the survivor)](https://durgical.com/en/conditions/sexual-violence/)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: [Clinical Guidance for PrEP](https://www.cdc.gov/hivnexus/hcp/prep/index.html) (Centers for Disease Control and Prevention (CDC), 2025); [Clinical Guidance for PEP](https://www.cdc.gov/hivnexus/hcp/pep/index.html) (Centers for Disease Control and Prevention (CDC), 2025); [Guidelines for HIV post-exposure prophylaxis](https://www.who.int/publications/i/item/9789240095137) (World Health Organization, 2024); [Profilaxis Preexposición al VIH (PrEP): Lineamiento para la implementación de la PrEP en Colombia](https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/lineamiento-profilaxis-preesposicion-vih-prep.pdf) (Ministerio de Salud y Protección Social (Colombia), 2023); [Body Fluid Exposures](https://www.ncbi.nlm.nih.gov/books/NBK557850/) (StatPearls (NCBI Bookshelf), 2023).

[← All conditions](https://durgical.com/en/conditions/)

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/conditions/hiv-pre-exposure-and-post-exposure-prophylaxis/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/conditions/hiv-pre-exposure-and-post-exposure-prophylaxis/
